• uncovered an intratumoral heterogeneity at the genomic and transcriptomic level.• deciphered a gene regulatory network underlying an invasive and poor prognosis state driven in part by the transcription factor HES6• HES6 is a valid target to stop uveal melanoma progression. The gene discussed is HES6; the disease is uveal melanoma.